Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Carlo Lazzaro, Cécile van Steen, Giorgio Ghirelli, Matteo Sacchi, Dario Sisto, Maurizio Uva, Luigi Varano & Luigi Angelillo. (2023) A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis. Expert Review of Pharmacoeconomics & Outcomes Research 23:2, pages 251-265.
Read now
Read now
Miguel A Teus, Jose I Belda, Cosme Lavín, Julián GarcÃa-FeijoÃ, H Falvey, Giorgio Buseghin, María Soler & Marilena Appierto. (2021) Cost-effectiveness analysis of iStent Inject® implantation during cataract surgery compared to cataract surgery alone for mild to moderate open-angle glaucoma patients in Spain. Expert Review of Ophthalmology 16:4, pages 319-328.
Read now
Read now
Robert M Feldman, George A Cioffi, Jeffrey M Liebmann & Robert N Weinreb. (2020) Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study. Clinical Ophthalmology 14, pages 729-739.
Read now
Read now
Anton Hommer. (2011) Role of fixed combinations in the management of open-angle glaucoma. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 91-99.
Read now
Read now
Articles from other publishers (7)
Shuang Zhang, Xuefang Jia, Ying Gao & Lingling Wu. (2023) Changes of the Types and Daily Costs of Topical Antiglaucoma Medications from 2006 to 2021 in China. Journal of Clinical Pharmacy and Therapeutics 2023, pages 1-9.
Crossref
Crossref
Xinghuai Sun, Ke Yao, Qinghuai Liu, Hong Zhang, Xiaoli Xing, Aiwu Fang, Xuanchu Duan, Minbin Yu, Michelle Y. Chen, Jingyuan Yang & Margot L. Goodkin. (2022) Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and Therapy 12:1, pages 341-353.
Crossref
Crossref
Konstantin Tachkov, Anton Vassilev & Stanislava Kostova. (2019) Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye. Frontiers in Public Health 7.
Crossref
Crossref
Gary C. BrownMelissa M. Brown. (2019) Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma. Journal of Ocular Pharmacology and Therapeutics 35:3, pages 145-160.
Crossref
Crossref
J.L. García-Pérez, B. Puerto-Hernández, G. Rebolleda Fernández, F.J. Muñoz-Negrete & C. González-Gordaliza. (2010) Evaluación mediante ecografía doppler color del efecto de la combinación fija bimatoprost/timolol sobre el flujo sanguíneo ocular en pacientes con hipertensión ocular. Estudio preliminar. Archivos de la Sociedad Española de Oftalmología 85:4, pages 131-137.
Crossref
Crossref
J.L. García-Pérez, B. Puerto-Hernández, G. Rebolleda Fernández, F.J. Muñoz-Negrete & C. González-Gordaliza. (2010) Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study. Archivos de la Sociedad Española de Oftalmología (English Edition) 85:4, pages 131-137.
Crossref
Crossref
. (2013) Bimatoprost/timolol of value for glaucoma in Europe. PharmacoEconomics & Outcomes News 551:1, pages 5-5.
Crossref
Crossref